News

DZHK registry shows how new therapies perform in routine clinical care

How does a new medicine perform once it is used in everyday clinical practice after approval? This is the question being investigated jointly by the…

Read more

Minimally Invasive Tricuspid Valve Repair Reduces Mortality and Hospitalisations

Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…

Read more

From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…

Read more

No Risk-Free Nicotine Use: International Research Team Maps the Biological Hierarchy Risks to the Cardiovascular System

A recent review led by University Medical Center Mainz, a partner site of the DZHK, compares the effects of cigarettes, waterpipes, heated tobacco…

Read more

Obesity drug significantly reduces the risk of serious cardiovascular events and infections

People with type 2 diabetes and obesity may benefit from treatment with tirzepatide. Tirzepatide, marketed under the brand name Mounjaro, can reduce…

Read more

Detecting cardiomyopathies in the magnetic field

The MagMa study by the DHZC, involving DZHK researchers, shows for the first time in a prospective study that radiation-free magnetocardiography can…

Read more